Showing results (171-180 of 222) with videos related to
Sort By:
Pageof 23
European Journal of Neurology|September 18, 2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseasesI Elovaara, S Apostolski, P van Doorn, et al.European Journal of Neurology|July 13, 2006
Guidelines for the treatment of autoimmune neuromuscular transmission disordersG O Skeie, S Apostolski, A Evoli, et al.Cellular Signalling|October 12, 2000
cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathwayC Ramstad, V Sundvold, H K Johansen, et al.Scandinavian Journal of Immunology|September 1, 1986
The terminal complement complex in sera deficient in the eighth component of complement (C8)T E Mollnes, T Lea, S Rogde, et al.Scandinavian Journal of Immunology|March 1, 1988
Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3cP Garred, T E Mollnes, T Lea, et al.Journal of the Neurological Sciences|March 1, 1987
Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complexT E Mollnes, B Vandvik, T Lea, et al.Aviation, Space, and Environmental Medicine|December 1, 1985
Further studies on the application of the compartmentalization/airlock concept to aircraft and spacecraftH S Fang, M L Tsai, I T LeaScandinavian Journal of Immunology|January 1, 1983
Heterogeneity of human amyloid protein AA and its related serum protein, SAAB Skogen, K Sletten, T Lea, et al.Scandinavian Journal of Immunology|August 1, 1985
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasmaT E Mollnes, T Lea, M Harboe, et al.Scandinavian Journal of Immunology|March 1, 1984
Enrichment of human epidermal Langerhans dendritic cellsS Bjercke, T Lea, L R Braathen, et al.Pageof 23